ADOCIA Alternatives & Competitors
12 companies similar to ADOCIA — "Innovative medicine for everyone, everywhere"
Companies similar to ADOCIA
Orgenesis Inc.
Unlocking the Potential of Cell and Gene Therapy for All (NASDAQ: ORGS)
Germantown, United States
ViaCyte
Regenerating Health: Transforming the lives of patients with insulin-requiring diabetes
San Diego, United States
Track all ADOCIA competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Scarlet Therapeutics Ltd
We believe the future of medicine is in our blood.
Bristol, United Kingdom
Akero Therapeutics
Restoring Balance. Renewing Life.
South San Francisco, Unit...
Likarda, Inc.
Transforming How Cell Therapies, Biologics, Peptides, and Hormones Are Delivered
Kansas City, United State...
Celularity Inc.
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...
United States
Antag Therapeutics
Redefining obesity treatment, empowering patients
Denmark
Morphic Medical
Innovative therapies for type 2 diabetes and obesity, rooted in excellence since 2003.
Boston, United States
NorthSea Therapeutics
Clinical-stage biopharmaceutical company focused on the development of structurally engine...
Amsterdam, The Netherland...
Magenta Therapeutics
Developing novel medicines to bring the curative power of stem cell transplants to more pa...
Cambridge, United States
About ADOCIA
Adocia is a clinical-stage biotech company focused on developing groundbreaking medications using innovative formulations of already-approved therapeutic proteins. Specializing in diabetes and obesity, the France-based company was founded in 2005 and is listed on the Euronext stock market. Adocia's proprietary BioChape...
Biotechnology research and development, product formulation, technology licensing
Patients with diabetes and obesity, pharmaceutical companies, research institutions, healthcare professionals
Clinical-stage, Medicine R&D, Therapeutic Proteins, Diabetes Treatment, Obesity Treatment, BioChaperone® Platform, Protein Formulations, Cell Therapy, Islet Transplantation, Metabolic Diseases, Injectable Formulations, Ultra-rapid Insulin, GLP-1, Amylin
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches ADOCIA and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at ADOCIA on 11 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
